Padmanabh P. Bhatt - Net Worth and Insider Trading
Padmanabh P. Bhatt Net Worth
The estimated net worth of Padmanabh P. Bhatt is at least $313,405 dollars as of 2024-12-01. Padmanabh P. Bhatt is the Sr. VP of IP, CSO of Supernus Pharmaceuticals Inc and owns about 8,570 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $313,405. Details can be seen in Padmanabh P. Bhatt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Padmanabh P. Bhatt has not made any transactions after 2024-03-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Padmanabh P. Bhatt
Padmanabh P. Bhatt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Padmanabh P. Bhatt owns 1 companies in total, including Supernus Pharmaceuticals Inc (SUPN) .
Click here to see the complete history of Padmanabh P. Bhatt’s form 4 insider trades.
Insider Ownership Summary of Padmanabh P. Bhatt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | 2024-03-21 | Sr. VP of IP & CSO |
Padmanabh P. Bhatt Latest Holdings Summary
Padmanabh P. Bhatt currently owns a total of 1 stock. Padmanabh P. Bhatt owns 8,570 shares of Supernus Pharmaceuticals Inc (SUPN) as of March 21, 2024, with a value of $313,405.
Latest Holdings of Padmanabh P. Bhatt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | 2024-03-21 | 8,570 | 36.57 | 313,405 |
Holding Weightings of Padmanabh P. Bhatt
Padmanabh P. Bhatt Form 4 Trading Tracker
According to the SEC Form 4 filings, Padmanabh P. Bhatt has made a total of 11 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Supernus Pharmaceuticals Inc is the sale of 14,491 shares on March 21, 2024, which brought Padmanabh P. Bhatt around $511,677.
Insider Trading History of Padmanabh P. Bhatt
- 1
Padmanabh P. Bhatt Trading Performance
Padmanabh P. Bhatt Ownership Network
Padmanabh P. Bhatt Owned Company Details
What does Supernus Pharmaceuticals Inc do?
Who are the key executives at Supernus Pharmaceuticals Inc?
Padmanabh P. Bhatt is the Sr. VP of IP & CSO of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include director & President & CEO Jack A. Khattar , Sr VP & Quality & GMP Oper. & IT Frank Mottola , and Sr. V.P. & Regulatory Affairs Tami Tillotson Martin .
Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary
Over the past 18 months, Padmanabh P. Bhatt made 6 insider transaction in Supernus Pharmaceuticals Inc (SUPN) with a net sale of 98,505. Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 38,886 shares made by Georges Gemayel , a net sale of 21,235 shares made by Tami Tillotson Martin , and a net sale of 250,000 shares made by Jack A. Khattar .
In summary, during the past 3 months, insiders sold 323,308 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 323,308 shares. During the past 18 months, 455,751 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 455,751 shares.
Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Supernus Pharmaceuticals Inc Insider Transactions
Padmanabh P. Bhatt Mailing Address
Above is the net worth, insider trading, and ownership report for Padmanabh P. Bhatt. You might contact Padmanabh P. Bhatt via mailing address: C/o Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
